- Stocks
- Pharma & Healthcare
- Veerhealth Care
Veerhealth Care share price
NSE: VEERHEALTHPharma & HealthcareDrug Manufacturers - Specialty & Generic
Veerhealth Care at a glance
With a market capitalisation of ₹58 Cr, it ranks 2986th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
Its return on equity was 1.8% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹17 Cr (+198.2% year on year) and net profit −₹0 Cr, on a standalone basis. Promoters held 31.91% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹58 CrRank 2986 on NSE
- Price to book
- 1.1×FY25
- EPS (TTM)
- ₹0.27to Q4 FY26
- ROE
- 1.8%FY25
- ROCE
- 2.6%FY25
- Debt to equity
- 0.22FY25
- Net profit margin
- 2.3%FY25
- Book value / share
- ₹11.11FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Veerhealth Care quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹6 Cr | ₹4 Cr | ₹4 Cr | ₹7 Cr | ₹17 Cr |
| Revenue YoY | −42.5% | +34.5% | +33.8% | +66.8% | +118.0% | −22.7% | +89.1% | +198.2% |
| Net profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | −₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | −₹0 Cr |
| Net profit YoY | −64.7% | −23.1% | −63.2% | — | +100.0% | −16.7% | +471.4% | — |
| Net margin | 5.8% | 5.8% | 1.8% | −1.8% | 5.3% | 6.3% | 5.5% | −2.1% |
| EPS | ₹0.06 | ₹0.15 | ₹0.04 | −₹0.05 | ₹0.12 | ₹0.13 | ₹0.20 | −₹0.18 |
Veerhealth Care financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹12 Cr | ₹11 Cr | ₹10 Cr | ₹13 Cr | ₹13 Cr | ₹17 Cr |
| Operating profit | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Net profit | ₹0 Cr | ₹0 Cr | −₹0 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr |
| EPS (₹) | ₹0.46 | ₹0.55 | −₹0.11 | ₹1.52 | ₹0.21 | ₹0.20 |
| Cash from operations | −₹0 Cr | ₹1 Cr | ₹2 Cr | −₹1 Cr | ₹3 Cr | −₹0 Cr |
| Total debt | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹4 Cr |
| Shareholders' equity | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹21 Cr | ₹22 Cr | ₹22 Cr |
Veerhealth Care shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 31.50% | 31.50% | 31.50% | 31.50% | 31.50% | 31.91% |
| Non-institutions | 68.50% | 68.50% | 68.50% | 68.50% | 68.50% | 68.09% |
Veerhealth Care vs peers
The listed Pharma & Healthcare companies nearest to Veerhealth Care by market capitalisation.
Ask anything about Veerhealth Care
Pivot answers on the live chart with evidence you can check, and tests strategies against VEERHEALTH's own history. Try: “Why has VEERHEALTH moved over the last three months?” · “Backtest a 50-day moving-average crossover on VEERHEALTH over five years” · “Compare VEERHEALTH with SAMRATPH on margins and valuation”
Frequently asked questions about Veerhealth Care
What is the market cap of Veerhealth Care?
Veerhealth Care's market capitalisation is ₹58 Cr (₹58 Cr) at the 22 Oct 2026 close, ranking 2986th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Veerhealth Care?
Return on equity was 1.8% in FY25 and return on capital employed was 2.6% in FY25 (standalone figures).
Is Veerhealth Care a debt-free company?
No. Veerhealth Care's debt-to-equity ratio was 0.22 in FY25, with total debt of ₹4 Cr.
What were Veerhealth Care's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Veerhealth Care reported revenue of ₹17 Cr, +198.2% year on year, and net profit of −₹0 Cr.
What is the shareholding pattern of Veerhealth Care?
As of 30 Jun 2026: promoters 31.91%, non-institutions 68.09%.
Who are Veerhealth Care's competitors?
The listed Pharma & Healthcare companies closest to Veerhealth Care by market cap are Samrat Pharma, Royal Sense, Bacil Pharma, Constronics Inf, Kabra Drugs and Bandaram Pharma.
Is Veerhealth Care a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Veerhealth Care's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on VEERHEALTH against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with V · all NSE stocks · this page as text